Global Genomic and Proteomic Profiling of African Children With Typhoid Fever

NCT02947295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 969

Last updated 2023-09-29

No results posted yet for this study

Summary

To develop a rapid, sensitive, and inexpensive diagnostic method, as well as more efficacious vaccine, for countries where typhoid fever remains a major public health burden.

Conditions

  • Typhoid Fever

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Stephen K Obaro, MD · Univeristy of Nebraska Medical Center

Eligibility

Min Age
1 Minute
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-13
Primary Completion
2017-03-01
Completion
2017-03-01

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02947295 on ClinicalTrials.gov